Diabetes

For those at high risk of diabetes, a threshold of four years of maintaining non-diabetic status could reduce the risk of death and cardiovascular complications.

Cohort study finds lower hazards of all-cause mortality, adverse cardiovascular events, acute kidney injury and adverse kidney events with tirzepatide versus GLP-1 RAs.

Study authors were so surprised by the results that one said ‘we did not believe it the first few times we saw it.’

With advertisements plastered everywhere from public transport vehicles to large billboards over highways and a proliferation of messages over social media, the buzz about GLP-1 receptor agonists is practically unavoidable.

Do you know which of your patients need to pay most attention to proper hydration?

The incidence of diabetes is estimated to be 27% in Canadians over 65 years of age.

As the sugar substitute is sometimes recommended for obesity control, authors call for immediate further study of xylitol and its possible side-effects.

Insulin icodec, which will be sold under the brand name Awiqli, is the first once-a-week basal insulin injection in the world and it will be available across the country starting June 30.